VibroSense Dynamics AB (public)sells and develops efficient systems to support early detection and diagnosis of sensory neuropathy, i.e. disease of large nerve fibres and nerve trunks in e.g. legs and arms. The Company, founded in 2005, has been listed on Spotlight stock market since May 2015. The company's customers are primary and specialist care, researchers, occupational health care, hospitals and health care centres.
Our vision is that the VibroSense Meter shall be the gold standard instrument for neurological examinations to assess sensory neuropathy and help to improve life conditions for patients having a risk of getting nerve injuries.